EP0119259A4 - Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization. - Google Patents

Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization.

Info

Publication number
EP0119259A4
EP0119259A4 EP19830903249 EP83903249A EP0119259A4 EP 0119259 A4 EP0119259 A4 EP 0119259A4 EP 19830903249 EP19830903249 EP 19830903249 EP 83903249 A EP83903249 A EP 83903249A EP 0119259 A4 EP0119259 A4 EP 0119259A4
Authority
EP
European Patent Office
Prior art keywords
immunization
characterization
diagnosis
purification
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19830903249
Other languages
German (de)
French (fr)
Other versions
EP0119259A1 (en
Inventor
Jack Wands
David A Shafritz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP0119259A1 publication Critical patent/EP0119259A1/en
Publication of EP0119259A4 publication Critical patent/EP0119259A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19830903249 1982-09-16 1983-09-16 Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization. Withdrawn EP0119259A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41870882A 1982-09-16 1982-09-16
US418708 1982-09-16

Publications (2)

Publication Number Publication Date
EP0119259A1 EP0119259A1 (en) 1984-09-26
EP0119259A4 true EP0119259A4 (en) 1988-08-04

Family

ID=23659257

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19830903249 Withdrawn EP0119259A4 (en) 1982-09-16 1983-09-16 Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization.

Country Status (3)

Country Link
EP (1) EP0119259A4 (en)
JP (1) JPS59501774A (en)
WO (1) WO1984001107A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (en) * 1987-02-20 1989-07-06 Seelig Renate VIRUSANT, METHOD FOR ITS OBTAINMENT AND USE IN DIAGNOSIS AND THERAPY (VACCINE)
FR2615863B1 (en) * 1987-05-26 1989-11-10 Inst Nat Sante Rech Med VIRUS RELATED TO VIRAL HEPATITIS B VIRUS, ITS VARIOUS CONSTITUENTS AND THEIR APPLICATION TO THE DIAGNOSIS OF VIRAL HEPATITIS AND TO VACCINATION AGAINST THIS DISEASE
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002598A1 (en) * 1979-05-21 1980-11-27 Us Commerce Detection of non-a,non-b hepatitis associated antigen
EP0027657A2 (en) * 1979-10-22 1981-04-29 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4291020A (en) * 1980-05-16 1981-09-22 The United States Of America As Represented By The Secretary Of Health & Human Services Inactivation of non-A, non-B hepatitis agent
WO1982002661A1 (en) * 1981-01-30 1982-08-19 Inc Centocor Immunoassay for multi-determinant antigens
WO1982003330A1 (en) * 1981-03-30 1982-10-14 Christian Trepo Method for the preparation of antigens of the viral hepatitis nanb,and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002598A1 (en) * 1979-05-21 1980-11-27 Us Commerce Detection of non-a,non-b hepatitis associated antigen
EP0027657A2 (en) * 1979-10-22 1981-04-29 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4291020A (en) * 1980-05-16 1981-09-22 The United States Of America As Represented By The Secretary Of Health & Human Services Inactivation of non-A, non-B hepatitis agent
WO1982002661A1 (en) * 1981-01-30 1982-08-19 Inc Centocor Immunoassay for multi-determinant antigens
WO1982003330A1 (en) * 1981-03-30 1982-10-14 Christian Trepo Method for the preparation of antigens of the viral hepatitis nanb,and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8401107A1 *

Also Published As

Publication number Publication date
WO1984001107A1 (en) 1984-03-29
JPS59501774A (en) 1984-10-25
EP0119259A1 (en) 1984-09-26

Similar Documents

Publication Publication Date Title
LTIP1793A (en) Method for detecting antibodies against hiv virus
EP0083286A3 (en) Modified vaccinia virus and methods for making and using the same
ZA829386B (en) Modified vaccinia virus and methods for making and using the same
IL73159A (en) Carboxyalkenamido-cephalosporins,processes for the preparation thereof and methods for the use thereof
EP0179139A4 (en) Leukemia-associated virus immunogen, vaccine and assay.
HK38293A (en) Hepatitis c virus
DE3882144D1 (en) POULTRONIC VIRUS PROMOTORS.
DE3266201D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain
EP0058676A4 (en) Non-a, non-b hepatitis assay and vaccine.
IL71274A0 (en) Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciferol
GB2212511B (en) Hepatitis c virus
EP0102381A4 (en) METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN LUNG TUMOR-ASSOCIATED ANTIGENS (hLTAA) AND CLINICAL DETECTION AND DETERMINATION OF THESE ANTIGENS.
ZA824319B (en) Process for the preparation of a polyolefin, and a catalyst for this process
IL70947A (en) Synthetic polypeptides from viral oncogenes,antigens,diagnostic reagents and vaccines including them,and method for using same for detecting diseases
EP0593290A3 (en) Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same.
IL67808A0 (en) Plant-promoting preparations,process for the manufacture thereof and methods for the use thereof
EP0608212A4 (en) Method of treating viral infection.
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
EP0240843A3 (en) Photosensitive composite, method for preparing it and use thereof
OA09026A (en) Method for detecting antibodies to human immunodeficiency virus.
EP0119259A4 (en) Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization.
EP0198828A4 (en) Infectious bursal disease virus vaccine.
IL79740A0 (en) Hepatitis vaccine
ZA878303B (en) A process for isolating and characterizing a new viral agent and its associated antigen,the antigen and viral agent obtained by this process,and detection procedures for non a,non b hepatitis using suitable immunological reagents
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19840516

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19880804

17Q First examination report despatched

Effective date: 19890605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19891017

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SHAFRITZ, DAVID, A.

Inventor name: WANDS, JACK